Latest filing published 06 Jan 2017 for Sucampo Pharmaceuticals, Inc., €1,414.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Andrew P. Smith: trading record in brief
Andrew P. Smith is a declared insider of Sucampo Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 16 November 2015 to 31 December 2016, the count stands at 6 filings.
In open-market terms, that means 1 purchase worth €26k on one side and 1 sale worth €26k on the other. On balance, insiders were net sellers of €49. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 4 share grants.
Most recently, on 6 January 2017, the filings show a share grant worth €1,414 in Sucampo Pharmaceuticals, Inc. The last purchase on record was published on 18 November 2015, which is 4,009 days ago. The median gap between a trade and its publication by SEC (Form 4) is 12 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andrew P. Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 143 shares@ US$10.464.5% of flowCommon Stock, Class A (ESPP)SEC:0001171843-17-000126:0
- 1,766 shares@ US$15.5881.9% of flowCommon Stock, Class ASEC:0001171843-16-013270:0
- 160 shares@ US$9.384.3% of flowCommon Stock, Class A (ESPP)SEC:0001171843-16-012577:0
- 188 shares@ US$9.325.1% of flowCommon Stock, Class A (ESPP)SEC:0001171843-16-011127:0
- 161 shares@ US$9.294.2% of flowCommon Stock, Class A (ESPP)SEC:0001171843-16-010711:0
- 1,605 shares@ US$17.03Class A Common StockSEC:0001171843-15-006412:0Canonical exit: 14 Feb 2016 (T+90)
6 of 6 declarations
